Disparities in the Use of Chemotherapy in Patients with Resected Pancreatic Ductal Adenocarcinoma.
Michael J WrightHeidi N OvertonJonathan A TeinorDing DingRichard A BurkhartJohn L CameronJin HeChristopher L WolfgangMatthew J WeissAmmar Asrar JavedPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2019)
Receipt of chemotherapy results in an improved survival in patients with resected PDAC. Demographic, racial, and geographic factors influence the rate of receipt of chemotherapy. Despite prior reports, these trends have not changed over the recent decades.